Dr. Rizvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7031 Southwest 62nd Avenue
South Miami, FL 33143Phone+1 305-284-7500
Summary
- A broadly trained physician scientist, educator, and healthcare provider with vast Clinical and Translational Research experience driving innovation within pharmaceutical product development platforms. Highly motivated and committed to advancing medical innovation, discovering new therapies, improving patient outcomes, and playing an instrumental role in scientific and business strategies. Equipped with diverse academic background and over 26 years of combined experience in academia, administrative, and healthcare settings.
Education & Training
- Harvard UniversityCertificate, Foundations of Clinical Research, 2022 - 2022
- University of Science, Arts and TechnologyMPH, Health Care Management, 2020 - 2022
- University of Science, Arts and TechnologyClass of 2022
- Cornell UniversityCertificate, Certificate in Executive Leadership, 2012 - 2013
- Aspen UniversityMBA, Pharmaceutical Marketing and Management, 2011 - 2012
- Mercer UniversityPhD, Pharmaceutical Sciences, 2006 - 2010
- Emory UniversityPostdoctorate, Organic and Surface Chemistry, Self-aggregating Systems, Soft Materials, 2006 - 2009
- Georgia State UniversityPhD, Analytical and Organic Chemistry, 2001 - 2006
Certifications & Licensure
- FL State Medical License 2022 - 2026
- Vascular Access Certification CorporationVascular Access Board Certified (VA-BC)
Awards, Honors, & Recognition
- Fellow of the Royal Society of Medicine (FRSM) Royal Society of Medicine
Clinical Trials
- Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors Start of enrollment: 2022 Apr 01
Publications & Presentations
PubMed
- 44 citationsTransdermal Bioavailability in Rats of Lidocaine in the Forms of Ionic Liquids, Salts, and Deep EutecticPaula Berton, Kristin R. Di Bona, Denise Yancey, Syed A. A. Rizvi, Marquita Gray
ACS Medicinal Chemistry Letters. 2017-04-19 - 514 citationsApplications of nanoparticle systems in drug delivery technologySyed A. A. Rizvi, Ayman M. Saleh
Saudi Pharmaceutical Journal. 2017-10-25 - 38 citationsRole of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of MetabolismRais A Ansari, Kazim Husain, Syed A. A. Rizvi
Biomolecules. 2016-06-24
Journal Articles
- Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studiesFernando Valerio-Pascua, Fernando Baires, Anupamjeet Kaur Sekhon, Mari L. Tesch, Estela Jackeline Pineda, Syed A. A. Rizvi, Jarmanjeet Singh, David Abraham Cortes-Band..., BMC Infectious Diseases, 11/26/2024
- Incretin mimetics for the management of diabetes and associated comorbidities: An overviewFaryal Haider, Syed M. Imam, Orien L. Tulp , Syed A. A. Rizvi, Innovative Medicines & Omics, 11/22/2024
- Exploring the key pathogenic mechanisms and potential intervention targets for Sophorae Flavescentis radix in managing bone metastasis of lung cancer based on network ...Yan Gao, Meng Wu, Syed A. A. Rizvi, Qiang Wei, Translational Cancer Research, 10/31/2024
- Join now to see all
Books/Book Chapters
Authored Content
- Drug Delivery Using NanomaterialsJanuary 2022
- Social Aspects of Drug Discovery, Development and CommercializationFebruary 2016
Press Mentions
- Separation by levitationApril 30th, 2022
Other Languages
- Hindi, Urdu
External Links
- Google Scholarhttps://scholar.google.com/citations?user=7DZNAncAAAAJ&hl=en
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: